SensDx Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
12
- Latest Deal Type
-
Out of Business
SensDx General Information
Description
Developer of a diagnostic testing technology designed to accurately identify specific diseases at home. The company's technology creates and develops diagnostic testing technologies, which include a simple tool based on a fast, ultra-sensitive diagnostic test with a mobile application for result interpretation, enabling doctors and medical professionals to track diseases and commence the correct therapy and treatment at an early stage.
Contact Information
Website
www.sensdx.euCorporate Office
- Ul. Kampinoska 25
- Gdansk, 80-180
- Poland
Corporate Office
- Ul. Kampinoska 25
- Gdansk, 80-180
- Poland
SensDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 10-Oct-2025 | Completed | Out of Business | |||
| 6. Accelerator/Incubator | 07-Oct-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | 12-Mar-2018 | Completed | Generating Revenue | |||
| 3. Corporate | 06-Jan-2018 | Completed | Generating Revenue | |||
| 2. Grant | 29-Nov-2017 | $35.2K | $50K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 24-May-2017 | $50K | $50K | Completed | Generating Revenue |
SensDx Patents
SensDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4644335-A1 | Ceramic-carbon foam electrodes enriched with metal oxides, their method of preparation, and use in electro-oxidation reactors | Pending | 29-Apr-2024 | ||
| EP-4454670-A1 | Polymer-ceramic biocomposites with pro-regenerative properties for filing bone defects and regenerating bone tissue and method of obtaining them | Pending | 28-Apr-2023 | ||
| WO-2024205433-A2 | Combinatorial 12mer amino acid sequences that specifically bind to pathogens responsible for bacterial vaginosis | Inactive | 31-Mar-2023 | ||
| WO-2024205433-A3 | Combinatorial 12mer amino acid sequences that specifically bind to pathogens responsible for bacterial vaginosis | Inactive | 31-Mar-2023 | ||
| WO-2024158303-A1 | The method of detecting streptococcus pneumoniae, primers, and detection kit for streptococcus pneumoniae | Inactive | 28-Jan-2023 | C12Q1/689 |
SensDx Signals
SensDx FAQs
-
When was SensDx founded?
SensDx was founded in 2014.
-
Where is SensDx headquartered?
SensDx is headquartered in Gdansk, Poland.
-
What is the size of SensDx?
SensDx has 12 total employees.
-
What industry is SensDx in?
SensDx’s primary industry is Diagnostic Equipment.
-
Is SensDx a private or public company?
SensDx is a Private company.
-
What is SensDx’s current revenue?
The current revenue for SensDx is .
-
How much funding has SensDx raised over time?
SensDx has raised $50K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process